Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances of computer-aided drug design (CADD) in the development of anti-Azheimer’s-disease drugs
Yuzhen Niu, Ping Lin
Drug Discovery Today (2023) Vol. 28, Iss. 8, pp. 103665-103665
Closed Access | Times Cited: 15

Showing 15 citing articles:

Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis
Zhenhui Wu, Shupeng Chen, Yihao Wang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 22
Discovery of sugar-based natural framework as phytopathogenic virus capsid protein inhibitors using a state-of-the-art multiple screening strategy
Jinhong Hu, Zhenxing Li, Yue Ding, et al.
International Journal of Biological Macromolecules (2025) Vol. 298, pp. 140075-140075
Closed Access | Times Cited: 1
A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects
Yi‐Ru Bai, Dong‐Jie Seng, Ying Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116706-116706
Closed Access | Times Cited: 6
ALZHEIMER'S DISEASE: COMPREHENSIVE INSIGHTS INTO RISK FACTORS, BIOMARKERS, AND ADVANCED TREATMENT APPROACHES
Suresh Janadri, SHREELAXMI DADMI, Manjunatha P. Mudagal, et al.
International Journal of Current Pharmaceutical Research (2025), pp. 1-10
Open Access
Design, synthesis, biological evaluation, and X‐ray single crystal structure of novel computer‐aided‐drug‐designbased α‐mangostin derivatives: Multifunctional ligands against Alzheimer's disease
Quanzhen Chen, Xiangyu Li, Wenting Xiao, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 3
Closed Access
Natural language processing in drug discovery: bridging the gap between text and therapeutics with artificial intelligence
Christine Ann Withers, Amina Mardiyyah Rufai, Aravind Venkatesan, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-19
Open Access
Exploring the Potential Mechanisms of Guanxinshutong Capsules in Treating Pathological Cardiac Hypertrophy based on Network Pharmacology, Computer-Aided Drug Design, and Animal Experiments
Yuanfeng Liu, Qi‐Xiang Li, Chongyu Shao, et al.
ACS Omega (2024) Vol. 9, Iss. 16, pp. 18083-18098
Open Access | Times Cited: 3
A review of the current trends in computational approaches in drug design and metabolism
Russell B. O. Ouma, Silas M. Ngari, Joshua K. Kibet
Deleted Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Surface Active Ligands for Enhanced Brain Targeting of Nanoparticles
A Prabakaran, Rajat Vashist, Sanchita Dhanchandra Sangave, et al.
(2024), pp. 241-262
Closed Access | Times Cited: 1
Novel Trifluoromethyl Containing Azo-Imin compounds: Synthesis, Characterization, and Investigation of Antioxidant Properties Using In Vitro and In Silico methods
Tolga A. Yeşil
Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi (2024), pp. 445-456
Open Access | Times Cited: 1
A computational and machine learning approach to identify GPR40-targeting agonists for neurodegenerative disease treatment
Arif Jamal Siddiqui, Riadh Badraoui, Mohammed Alshahrani, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0306579-e0306579
Open Access | Times Cited: 1
Overcoming MTDH and MTDH-SND1 complex: driver and potential therapeutic target of cancer
Hao Shen, Jiayu Ding, Jiaying Ji, et al.
Cancer Insight (2023) Vol. 3, Iss. 1, pp. 37-48
Open Access | Times Cited: 3
The mechanism of action and chemical synthesis of FDA newly approved drug molecules
Dandan Shen, Yuelin Zhang, Xiang Li, et al.
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access
Molecular Databases
Daniela Quadros de Azevedo, Rachel Oliveira Castilho, Alejandro Gómez‐García, et al.
(2024), pp. 15-43
Closed Access
Developing public–private R&D consortia to accelerate Alzheimer’s disease drug development
Joel West, Paul Olk
Drug Discovery Today (2024) Vol. 29, Iss. 9, pp. 104103-104103
Open Access
Advances and challenges in drug design against dental caries: application of in silico approaches
Zaidie Chen, Xinyao Zhao, Hanyu Zheng, et al.
Journal of Pharmaceutical Analysis (2024), pp. 101161-101161
Open Access
Page 1

Scroll to top